Download presentation
Presentation is loading. Please wait.
Published byEmerald Tucker Modified over 6 years ago
1
Trends and Racial Differences in the Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer April P. Carson, PhD, Daniel L. Howard, PhD, William R. Carpenter, PhD, Yhenneko J. Taylor, MS, Sharon Peacock, MS, Anna P. Schenck, PhD, Paul A. Godley, MD, PhD Journal of Pain and Symptom Management Volume 39, Issue 5, Pages (May 2010) DOI: /j.jpainsymman Copyright © Terms and Conditions
2
Fig. 1 Proportion of men receiving LHRH agonists, orchiectomy, or no ADT, by diagnosis year for African-American and white men with metastatic prostate cancer, SEER-Medicare 1991–1999. Journal of Pain and Symptom Management , DOI: ( /j.jpainsymman ) Copyright © Terms and Conditions
3
Fig. 2 Probability of receipt of ADT during months following diagnosis by race, SEER-Medicare 1991–1999. Journal of Pain and Symptom Management , DOI: ( /j.jpainsymman ) Copyright © Terms and Conditions
4
Fig. 3 Proportion of men treated with an orchiectomy or an LHRH agonist by race, among those receiving ADT, SEER-Medicare 1991–1999. Journal of Pain and Symptom Management , DOI: ( /j.jpainsymman ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.